Background: Liquid injectable silicone (LIS) is controversially used for soft-tissue augmentation, frequently causing severe, late-onset foreign body granulomas. Complete surgical removal is nearly impossible due to silicone migration, with residues leading to high recurrence. Meanwhile, medical therapies alone do not address macroscopic structural deformity. This study evaluates a combined protocol of subdermal granulectomy followed by adjuvant intralesional steroids for chin siliconomas. Methods: An ambidirectional cohort study (2015–2025) evaluated 35 patients with LIS-induced chin granulomas. All subjects underwent submental granulectomy. Postoperatively, patients were allocated to an adjuvant steroid cohort (n = 17) or a surgery-only control cohort (n = 18). The outcomes included aesthetic improvements (chin shape and erythema) and recurrence-free survival. Results: Granulectomy yielded significant improvements in aesthetics (p = 0.001) and erythema (p < 0.001) with a 2.86% complication rate. Longitudinal survival analysis demonstrated that adjuvant steroids lowered the crude recurrence rate (5.89% vs. 44.4%, p = 0.018) and significantly extended recurrence-free survival (Log-rank p = 0.016). The surgery-only cohort exhibited higher recurrence risk (Cox hazard ratio = 8.59, p = 0.043). Over the follow-up period, the surgery-only cohort experienced significant aesthetic deterioration (p = 0.04) and persistent redness, whereas the steroid cohort preserved postsurgical chin shape (p = 0.19) and achieved further erythema reduction (p = 0.03). Multivariable regression indicated higher odds of aesthetic preservation (adjusted odds ratio [aOR] = 3.85, p = 0.082) and erythema resolution (aOR = 2.90, p = 0.145) in the steroid cohort, although statistical significance was not reached. Conclusions: Our subdermal granulectomy technique successfully removed macroscopic silicone burden while maintaining the appearance of the anterior chin. The implementation of an early adjuvant steroid protocol provides a synergistic advantage by neutralizing residual microscopic inflammation, delaying recurrence, and ensuring durable aesthetic outcomes.
1 July 2026 in Journal of Pharmacy & Pharmacognosy Research
Context: Delayed inflammatory reactions at cosmetic implant sites have been reported after coronavirus disease 2019 vaccination, but population-level data from Indonesia remain limited. Aims: To estimate the prevalence of self-reported implant-site inflammatory reactions after coronavirus disease 2019 vaccination among cosmetic implant users in Indonesia and to explore associated factors. Methods: A cross-sectional online survey was distributed in Indonesia from November 2021 to July 2022. Respondents receiving at least one coronavirus disease 2019 vaccine dose who reported having a cosmetic implant were included. The primary outcome was self-reported localized redness, swelling, or pain at the implant site rather than clinically verified foreign-body reaction. Results: Among 1,610 valid responses, 266 respondents reported having cosmetic implants. Implant-site inflammatory reactions were reported by 10 respondents, corresponding to a period prevalence of 3.76% (95% CI: 1.82–6.80%). Adverse vaccine reactions were reported by 91 respondents (34.2%). An exploratory analysis suggested these respondents had higher odds of implant-site inflammatory reactions (OR: 4.78; 95% CI: 1.21–18.94; p = 0.04). However, this finding must be interpreted cautiously because only 10 events were observed and multivariable adjustment was not possible. No significant association was observed with age, sex, or vaccine type. Conclusions: A small proportion of respondents with cosmetic implants reported implant-site inflammatory symptoms following coronavirus disease 2019 vaccination. Because outcomes were self-reported, derived from a cross-sectional design, and key confounders were unmeasured, causal interpretation remains uncertain. These findings should be interpreted strictly as hypothesis-generating pharmacovigilance evidence. Prospective, clinically validated studies incorporating detailed implant characterization and reaction timing are required.